ASTM Key Stats
- Final Trade: Your First Move for Tuesday, May 28 May 24
- AASTROM BIOSCIENCES INC Files SEC form 8-K, Notice of Delisting or Failure to Sa... May 24
- AASTROM BIOSCIENCES INC Financials May 15
- AASTROM BIOSCIENCES INC Files SEC form 8-K, Notice of Delisting or Failure to Sa... May 13
- Aastrom Biosciences Management Discusses Q1 2013 Results - Earnings Call Transcr... May 9
- AASTROM BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial ... May 8
- Aastrom Biosciences, Inc. (ASTM) Posts Q1 Loss of 15c/Share Street Insider May 8
- Aastrom Biosciences Reports First Quarter 2013 Financial Results GlobeNewswire May 8
- AASTROM BIOSCIENCES INC Files SEC form 10-Q, Quarterly Report May 8
- Q1 2013 Aastrom Biosciences Earnings Release - After Market Close May 8
ASTM Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Aastrom Biosciences is down 73.58% over the last year vs S&P 500 Total Return up 27.96%, Neuralstem up 56.04%, and Cytori Therapeutics up 15.21%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Pro Ratings for ASTM
Pro Report PDF for ASTM
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download ASTM Pro Report PDF
Pro Strategies Featuring ASTM
Did Aastrom Biosciences make it into our Pro Portfolio Strategies?